The Mayo Clinic Center for Regenerative Biotherapeutics manufactures a wide range of products for active, early-phase clinical trials.

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.

By Deena Beasley (Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...